Clinical assessments in male and female patients with axial SpA
| All patients (n=469) | Males (n=310) | Females (n=159) | P-value | |
|---|---|---|---|---|
| BASDAI | 3.6 (0.0–9.6) | 3.4 (0.0–9.4) | 4.2 (0.2–9.6) | 0.000 |
| ASDAS (CRP) | 2.3 (0.0–5.7) | 2.2 (0.0–5.2) | 2.5 (0.6–5.7) | 0.004 |
| Patient GDA | 4 (0–10) | 3 (0–10) | 5 (0–10) | 0.001 |
| CRP (mg/L) | 3 (0–94) | 3 (0–94) | 3 (0–82) | 0.415 |
| CRP ≥5 | 176 (38%) | 115 (38%) | 61 (39%) | 0.731 |
| Swollen joints | 0 (0–9) | 0 (0–9) | 0 (0–2) | 0.576 |
| ≥1 swollen joint | 18 (4%) | 13 (4%) | 5 (3%) | 0.575 |
| Tender joints | 0 (0–22) | 0 (0–22) | 0 (0–19) | 0.018 |
| ≥1 tender joint | 108 (23%) | 61 (20%) | 47 (30%) | 0.020 |
| BASFI | 3.3 (0.0–9.9) | 3.0 (0.0–9.7) | 4.0 (0.0–9.9) | 0.030 |
| ASQoL | 6 (0–18) | 4 (0–18) | 7 (0–18) | 0.000 |
Values are presented as median (range) or number of patients (%).